[go: up one dir, main page]

NO20043988L - Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner - Google Patents

Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner

Info

Publication number
NO20043988L
NO20043988L NO20043988A NO20043988A NO20043988L NO 20043988 L NO20043988 L NO 20043988L NO 20043988 A NO20043988 A NO 20043988A NO 20043988 A NO20043988 A NO 20043988A NO 20043988 L NO20043988 L NO 20043988L
Authority
NO
Norway
Prior art keywords
chiral
preparation
substituted piperazines
piperazines
substituted
Prior art date
Application number
NO20043988A
Other languages
English (en)
Norwegian (no)
Inventor
Gregg Brian Feigelson
Joseph Zeldis
Ivo Jirkovsky
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20043988L publication Critical patent/NO20043988L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/06—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing halogen atoms, or nitro or nitroso groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20043988A 2002-03-12 2004-09-23 Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner NO20043988L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36345802P 2002-03-12 2002-03-12
PCT/US2003/007176 WO2003078420A2 (fr) 2002-03-12 2003-03-10 Methode de production de piperazines chiraux 1,4-disubstitues

Publications (1)

Publication Number Publication Date
NO20043988L true NO20043988L (no) 2004-09-23

Family

ID=28041772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043988A NO20043988L (no) 2002-03-12 2004-09-23 Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner

Country Status (20)

Country Link
US (3) US7019137B2 (fr)
EP (1) EP1483256A2 (fr)
JP (1) JP2005527530A (fr)
KR (1) KR20040091119A (fr)
CN (2) CN100451014C (fr)
AR (1) AR038931A1 (fr)
AU (1) AU2003220110B2 (fr)
BR (1) BR0308347A (fr)
CA (1) CA2477906A1 (fr)
CR (1) CR7428A (fr)
EC (1) ECSP045292A (fr)
IL (1) IL163828A0 (fr)
MX (1) MXPA04008730A (fr)
NO (1) NO20043988L (fr)
NZ (1) NZ535169A (fr)
RU (2) RU2315044C2 (fr)
TW (1) TW200304825A (fr)
UA (1) UA79774C2 (fr)
WO (1) WO2003078420A2 (fr)
ZA (1) ZA200408205B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007956A1 (fr) 2001-07-20 2003-01-30 Psychogenics, Inc. Traitement des troubles de deficit de l'attention/hyperactivite
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
RU2315044C2 (ru) * 2002-03-12 2008-01-20 Уайт Способ получения хиральных 1,4-дизамещенных пиперазинов
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
EP2896624B1 (fr) 2007-03-28 2016-07-13 Atir Holding S.A. Composés hétérocycliques comme agents sérotoninergiques et dopaminergiques et leurs utilisations
CN108627380B (zh) * 2017-03-15 2020-10-20 中国人民解放军军事医学科学院毒物药物研究所 去除或减少有毒物质的方法以及检测有毒物质的方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE960203C (de) * 1953-12-25 1957-03-21 Yoshitomi Pharmaceutical Verfahren zur Herstellung von N-substituierten Aminocarbonsaeureestern
AU577802B2 (en) * 1983-10-17 1988-10-06 Duphar International Research B.V. Blood-pressure lowering piperazine derivatives
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
AU645681B2 (en) 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
IL105348A0 (en) * 1992-04-13 1993-08-18 Fujisawa Pharmaceutical Co Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds
WO1994024115A1 (fr) 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Nouveau derive de piperazine
GB9411099D0 (en) 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
JPH10504275A (ja) 1994-06-03 1998-04-28 ジョン・ワイス・アンド・ブラザー・リミテッド ピペラジン誘導体を製造するための新規な方法および中間体
GB9413772D0 (en) 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
CA2196769C (fr) * 1994-08-05 2002-10-08 William S. Faraci Derives de benzimidazole presentant une activite dopaminergique
US5681958A (en) * 1995-06-07 1997-10-28 Shaman Pharmaceuticals, Inc. Cryptolepine analogs with hypoglycemic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
GB9514901D0 (en) 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
WO1997037655A1 (fr) 1996-04-10 1997-10-16 Merck & Co., Inc. ANTAGONISTES DU RECEPTEUR αvβ3
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
JPH11106381A (ja) * 1997-09-30 1999-04-20 Ss Pharmaceut Co Ltd クロメン誘導体及びその塩並びにこれを含有する医薬
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents
US6875772B2 (en) * 2001-11-30 2005-04-05 Schering Corporation [1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists
ATE439356T1 (de) * 2002-03-12 2009-08-15 Wyeth Corp Verfahren zur herstellung von chiralen n-aryl piperazinen
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
ES2334836T3 (es) * 2002-03-12 2010-03-16 Wyeth Preparacion de 2-((2,3-dihidro-benzo(1,4)dioxin-5-il)-(2-hidroxietil)-amino)-etanol y productos intermedios correspondientes.
RU2315044C2 (ru) * 2002-03-12 2008-01-20 Уайт Способ получения хиральных 1,4-дизамещенных пиперазинов
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines

Also Published As

Publication number Publication date
AU2003220110B2 (en) 2009-04-09
ZA200408205B (en) 2007-03-28
WO2003078420A3 (fr) 2004-03-11
RU2007125687A (ru) 2009-01-20
TW200304825A (en) 2003-10-16
AU2003220110A1 (en) 2003-09-29
BR0308347A (pt) 2005-01-25
RU2004130313A (ru) 2005-04-10
US7256289B2 (en) 2007-08-14
MXPA04008730A (es) 2004-12-06
WO2003078420A2 (fr) 2003-09-25
CN101492383A (zh) 2009-07-29
RU2315044C2 (ru) 2008-01-20
UA79774C2 (en) 2007-07-25
US20030208075A1 (en) 2003-11-06
CN100451014C (zh) 2009-01-14
NZ535169A (en) 2006-03-31
US20080058543A1 (en) 2008-03-06
US20050228181A1 (en) 2005-10-13
AR038931A1 (es) 2005-02-02
IL163828A0 (en) 2005-12-18
JP2005527530A (ja) 2005-09-15
CA2477906A1 (fr) 2003-09-25
KR20040091119A (ko) 2004-10-27
CN1642937A (zh) 2005-07-20
EP1483256A2 (fr) 2004-12-08
CR7428A (es) 2008-09-23
ECSP045292A (es) 2004-10-26
US7019137B2 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
LTPA2014013I1 (lt) Fenilpiperazino dariniai, kaip serotonino grįžtamos absorbcijos inhibitoriai
NO20053115D0 (no) Fremgangsmate for fremstilling av 2'-forgrenede nukleosider.
NO20041452L (no) 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer.
NO20021559L (no) Fremgangsmåte til gjenvinning av ammoniakk
NO20033433L (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
IS7239A (is) Aðferð til framleiðslu á essítalóprami
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20052262D0 (no) Fremgangsmate til fremstilling av 4-substituerte 2,2,6,6-tetrametyl-piperidin-N-oksy- og 2,2,6,6-tetrametyl-piperidin-N-hydroksy-forbindelser
NO20031754D0 (no) Fremgangsmåte for fremstilling av mesylater av piperzinderivater
IL172542A0 (en) 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
NO20043988L (no) Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20041224L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
ITMI20011205A0 (it) Processo integrato di produzione di 2,6 dimetilfaftalene
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
EP1565448A4 (fr) Procede de preparation de 10h-dibenzo b,f 1,4 thiazepin-11-one
ITMI20030346A1 (it) Procedimento per la produzione di mesitilene.
AU2003250860A8 (en) Chiral 3,4-dihydro-2h-pyran compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application